Last reviewed · How we verify

NCT05005858: MRS

Modified Ridge Splitting Technique Using Autogenous Bone Blocks (MRS)

Status unknown NA Last updated 16 August 2021
What this trial tests

NA trial testing Alveolar ridge splitting in Alveolar Bone Resorption in 40 participants. Status unknown.

Timeline
14 May 2019
Primary endpoint
1 August 2020
1 January 2023

Quick facts

Lead sponsorSemmelweis University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment40
Start date14 May 2019
Primary completion1 August 2020
Estimated completion1 January 2023
Sites1 location across Hungary

Drugs / interventions tested

Conditions studied

Sponsor

Semmelweis University

Who can join

18 and older, any sex, with Alveolar Bone Resorption or Alveolar Ridge Enlargement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this clinical study ridge splitting procedures are preformed using autogenous bone blocks. After a 3-month healing, at the time of dental implant placement bone core biopsy samples are harvested. The samples undergo micro-Ct and histomorphometric analysis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Microarchitectural Study of the Augmented Bone Following a Modified Ridge Splitting Technique: Histological and Micro-Computed Tomography Analyses.
    Pénzes D, Szerencse C, Major M, Szabó G, et al · · 2024 · PMID 39597823 · DOI 10.3390/jcm13226679

Verify or expand the search:

Other recruiting trials for Alveolar Bone Resorption

Currently open trials in the same condition.

Other Semmelweis University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05005858.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing